Mitch C. Hill - 10 May 2021 Form 4 Insider Report for Inari Medical, Inc.

Signature
/s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
Issuer symbol
N/A
Transactions as of
10 May 2021
Net transactions value
-$449,861
Form type
4
Filing time
11 May 2021, 18:54:56 UTC
Previous filing
20 Jan 2022
Next filing
09 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $2,285 +5,000 +7.4% $0.4570* 72,937 10 May 2021 Direct
transaction NARI Common Stock Sale $74,929 -845 -1.2% $88.67 72,092 10 May 2021 Direct F1, F2
transaction NARI Common Stock Sale $130,668 -1,455 -2% $89.81 70,637 10 May 2021 Direct F1, F3
transaction NARI Common Stock Sale $209,614 -2,300 -3.3% $91.14 68,337 10 May 2021 Direct F1, F4
transaction NARI Common Stock Sale $36,936 -400 -0.59% $92.34 67,937 10 May 2021 Direct F1, F5
holding NARI Common Stock 1,600 10 May 2021 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to buy) Options Exercise $0 -5,000 -1.6% $0.000000 301,977 10 May 2021 Common Stock 5,000 $0.4570 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $88.31 to $89.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $89.41 to $90.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $90.65 to $91.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $92.16 to $92.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 Option vested with respect to 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter.